Anti-IL-12/IL-23p40 (CNTO 1275 (Ustekinumab))

Anti-IL-12/IL-23p40 [CNTO 1275 (Ustekinumab)], Recombinant, IgG1 kappa, Human
SKU
ABAAb04238-10.0
Packaging Unit
100 μg
Manufacturer
Absolute Antibody

Availability: loading...
Price is loading...
CloneID: CNTO 1275 (Ustekinumab)

Antigen Long Description: The original antibody was produced by immunizing human immunoglobulin transgenic mice ((CBA/J×C57/BL6/J) F2 hybrid) with human recombinant IL-12.

Buffer Composition: PBS with 0.02% Proclin 300.

Available Custom Conjugation Options: AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7

Specificity Statement: This antibody is specific for the p40 subunit of human IL-12/23.

Application Notes (Clone): This antibody inhibits the interactions of IL-12 and IL-23 with the cell surface IL-12Rβ1 receptor and has been evaluated in phase I, II, and III trials as a treatment for immune-mediated diseases such as psoriasis, psoriatic arthritis, Crohn’s disease, multiple sclerosis, and ulcerative colitis (Elliott et al., 2009; PMID: 20074279) (Sands et al., 2019; PMID: 31553833).
More Information
SKU ABAAb04238-10.0
Manufacturer Absolute Antibody
Manufacturer SKU Ab04238-10.0
Package Unit 100 μg
Quantity Unit STK
Reactivity Human
Clonality Recombinant
Application Blocking, In Vivo Assay
Isotype IgG1 kappa
Host Human
Product information (PDF) Download
MSDS (PDF) Download